Bharat Biotech's Covaxin gets SEC approval on its Phase 3 trials efficacy data

Bharat Biotech will also hold a ‘pre-submission’ meeting on Wednesday with the World Health Organization, regarding the approval for Covaxin.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3zLZMmh
via IFTTT